SY007 in Patients With Acute Ischemic Stroke
Clinical trial NCT04891913 · SUSPENDED
Trial details
- NCT number
- NCT04891913
- Sponsor
- Suzhou Yabao Pharmaceutical R&D Co., Ltd.
- Status
- SUSPENDED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-07-01
- Primary completion
- 2023-12-25
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.